Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › OX40L fusion protein for the immunotherapy of tumors of veterinary animals

OX40L fusion protein for the immunotherapy of tumors of veterinary animals

US Patent 10196435 · Granted Feb 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2025
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2025
Lym-1 and Lym-2 antibody compositions and improved car constructs2023
Lym-1 and Lym-2 antibody compositions and improved car constructs2023
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2022
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2022
Car t-cell therapy directed to LHR for the treatment of solid tumors2021
Car t-cell therapy directed to LHR for the treatment of solid tumors2021
CD20 scFv-ELPs methods and therapeutics2021
CD20 scFv-ELPs methods and therapeutics2021
Lym-1 and Lym-2 targeted CAR cell immunotherapy2020
Annexin II variant compositions and methods2019